{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:30:53Z","timestamp":1793395853220,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.drudis.2026.104836","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:01:47Z","timestamp":1792162907000},"page":"104836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1428-8218","authenticated-orcid":false,"given":"Soukaina","family":"Amniouel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8710-9938","authenticated-orcid":false,"given":"Zeenat A.","family":"Shyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewy A.","family":"Math\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1034-0757","authenticated-orcid":false,"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104836_b0005","unstructured":"Genetic and Rare Diseases Information Center (GARD). What Is A Rare Disease? https:\/\/rarediseases.info.nih.gov\/about. Accessed April 24, 2026."},{"key":"10.1016\/j.drudis.2026.104836_b0010","unstructured":"US Food and Drug Administration (FDA). Rare Diseases at FDA. www.fda.gov\/patients\/rare-diseases-fda. Accessed April 24, 2026."},{"key":"10.1016\/j.drudis.2026.104836_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1021920","article-title":"Stepwise use of genomics and transcriptomics technologies increases diagnostic yield in Mendelian disorders","volume":"11","author":"Colin","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.drudis.2026.104836_b0020","unstructured":"US Food and Drug Administration (FDA). FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs. www.fda.gov\/news-events\/press-announcements\/fda-announces-plan-phase-out-animal-testing-requirement-monoclonal-antibodies-and-other-drugs. Published April 10, 2025. Accessed April 24, 2026."},{"key":"10.1016\/j.drudis.2026.104836_b0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13023-023-02790-7","article-title":"A comprehensive study of the rare diseases and conditions targeted by orphan drug designations and approvals over the forty years of the Orphan Drug Act","volume":"18","author":"Fermaglich","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.drudis.2026.104836_b0030","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1038\/s41467-022-31030-y","article-title":"Common genetic variation associated with Mendelian disease severity revealed through cryptic phenotype analysis","volume":"13","author":"Blair","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104836_b0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/genes11030239","article-title":"Genetic modifiers and rare Mendelian disease","volume":"11","author":"Rahit","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.drudis.2026.104836_b0040","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1038\/s41467-024-52407-1","article-title":"Complex trait associations in rare diseases and impacts on Mendelian variant interpretation","volume":"15","author":"Smail","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104836_b0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cpt.3631","article-title":"Challenges and possible strategies to address them in rare disease drug development: a statistical perspective","volume":"118","author":"Chen","year":"2025","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.drudis.2026.104836_b0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrg3920","article-title":"Machine learning applications in genetics and genomics","volume":"16","author":"Libbrecht","year":"2015","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.drudis.2026.104836_b0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41576-019-0100-z","article-title":"Induced pluripotent stem cells in disease modelling and drug discovery","volume":"20","author":"Rowe","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.drudis.2026.104836_b0060","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.3390\/ijms26094367","article-title":"Organoids-on-chips technology: unveiling new perspectives in rare-disease research","volume":"26","author":"Li","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104836_b0065","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jimd.12663","article-title":"Integrative omics approaches to advance rare disease diagnostics","volume":"46","author":"Smirnov","year":"2023","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.drudis.2026.104836_b0070","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.stem.2016.04.013","article-title":"Induced pluripotent stem cells meet genome editing","volume":"18","author":"Hockemeyer","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.drudis.2026.104836_b0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jacc.2014.04.057","article-title":"Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing","volume":"64","author":"Wang","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.drudis.2026.104836_b0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol"},{"key":"10.1016\/j.drudis.2026.104836_b0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13059-020-02015-1","article-title":"MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data","volume":"21","author":"Argelaguet","year":"2020","journal-title":"Genome Biol"},{"key":"10.1016\/j.drudis.2026.104836_b0090","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41592-023-01886-z","article-title":"Machine learning in rare disease","volume":"20","author":"Banerjee","year":"2023","journal-title":"Nat Methods"},{"key":"10.1016\/j.drudis.2026.104836_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2021.107739","article-title":"Using machine learning approaches for multi-omics data analysis: a review","volume":"49","author":"Reel","year":"2021","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.drudis.2026.104836_b0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41587-021-01001-7","article-title":"Mapping single-cell data to reference atlases by transfer learning","volume":"40","author":"Lotfollahi","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.drudis.2026.104836_b0105","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41592-024-02390-8","article-title":"Small data methods in omics: the power of one","volume":"21","author":"Johnston","year":"2024","journal-title":"Nat Methods"},{"key":"10.1016\/j.drudis.2026.104836_b0110","first-page":"1370","article-title":"Network approaches to systems biology analysis of complex disease: integrative methods for multi-omics data","volume":"19","author":"Yan","year":"2018","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.drudis.2026.104836_b0115","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1074\/mcp.TIR118.001251","article-title":"MOGSA: integrative single sample gene-set analysis of multiple omics data","volume":"18","author":"Meng","year":"2019","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.drudis.2026.104836_b0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.drudis.2026.104836_b0125","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104836_b0130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrg3555","article-title":"Rare-disease genetics in the era of next-generation sequencing: discovery to translation","volume":"14","author":"Boycott","year":"2013","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.drudis.2026.104836_b0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13023-017-0755-5","article-title":"An overview of the impact of rare disease characteristics on research methodology","volume":"13","author":"Whicher","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.drudis.2026.104836_b0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41576-023-00683-w","article-title":"The expanding diagnostic toolbox for rare genetic diseases","volume":"25","author":"Kernohan","year":"2024","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.drudis.2026.104836_b0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jclinepi.2021.12.009","article-title":"Design and analysis features used in small population and rare disease trials: a targeted review","volume":"144","author":"Partington","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.drudis.2026.104836_b0150","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1965","article-title":"Small data challenges of studying rare diseases","volume":"3","author":"Mitani","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.drudis.2026.104836_b0155","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13167-016-0074-2","article-title":"Discovery of biomarkers in rare diseases: innovative approaches by predictive and personalized medicine","volume":"7","author":"G\u00fclbakan","year":"2016","journal-title":"EPMA J"},{"key":"10.1016\/j.drudis.2026.104836_b0160","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41582-023-00811-4","article-title":"Mechanisms underlying phenotypic variation in neurogenetic disorders","volume":"19","author":"Burgunder","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.drudis.2026.104836_b0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10545-018-0146-7","article-title":"The functional genomics laboratory: functional validation of genetic variants","volume":"41","author":"Rodenburg","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.drudis.2026.104836_b0170","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00439-023-02639-w","article-title":"Functional categorization of gene regulatory variants that cause Mendelian conditions","volume":"143","author":"Cheng","year":"2024","journal-title":"Hum Genet"},{"key":"10.1016\/j.drudis.2026.104836_b0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13023-020-01376-x","article-title":"A scoping review and proposed workflow for multi-omic rare disease research","volume":"15","author":"Kerr","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.drudis.2026.104836_b0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","article-title":"Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications","volume":"9","author":"Cerneckis","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.drudis.2026.104836_b0185","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2026.104836_b0190","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s44222-022-00013-5","article-title":"CRISPR engineering in organoids for gene repair and disease modelling","volume":"1","author":"Geurts","year":"2023","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.drudis.2026.104836_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1686438","article-title":"Studying rare diseases using induced pluripotent stem cell (iPSC)-based model systems","volume":"13","author":"Francis","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.drudis.2026.104836_b0200","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature09855","article-title":"Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome","volume":"471","author":"Yazawa","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104836_b0205","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1038\/ncomms7955","article-title":"Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy","volume":"6","author":"Karakikes","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104836_b0210","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41573-025-01317-y","article-title":"Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges","volume":"25","author":"Wang","year":"2026","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2026.104836_b0215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41586-024-08462-1","article-title":"Rapid and scalable personalized ASO screening in patient-derived organoids","volume":"638","author":"Means","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104836_b0220","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm.3201","article-title":"A functional CFTR assay using primary cystic fibrosis intestinal organoids","volume":"19","author":"Dekkers","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2026.104836_b0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41231-020-00060-3","article-title":"Rationale and design of the HIT-CF organoid study: stratifying cystic fibrosis patients based on intestinal organoid response to different CFTR-modulators","volume":"5","author":"van Mourik","year":"2020","journal-title":"Transl Med Commun"},{"key":"10.1016\/j.drudis.2026.104836_b0230","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41390-024-03728-w","article-title":"Implementation of multi-omics in diagnosis of pediatric rare diseases","volume":"97","author":"Ali","year":"2025","journal-title":"Pediatr Res"},{"key":"10.1016\/j.drudis.2026.104836_b0235","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1358863X251394285","article-title":"Harnessing iPSCs, 3D organoids, and multiomics to model rare vascular diseases: emerging new approach methodologies","volume":"31","author":"Liu","year":"2026","journal-title":"Vasc Med"},{"key":"10.1016\/j.drudis.2026.104836_b0240","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molmed.2017.02.007","article-title":"Disease modeling in stem cell-derived 3D organoid systems","volume":"23","author":"Dutta","year":"2017","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.drudis.2026.104836_b0245","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10545-018-0154-7","article-title":"Multiomics tools for the diagnosis and treatment of rare neurological disease","volume":"41","author":"Crowther","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.drudis.2026.104836_b0250","article-title":"Toward transcriptomics as a primary tool for rare disease investigation","volume":"8","author":"Montgomery","year":"2022","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"10.1016\/j.drudis.2026.104836_b0255","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.copbio.2018.11.002","article-title":"High-throughput single-cell transcriptomics on organoids","volume":"55","author":"Brazovskaja","year":"2019","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.drudis.2026.104836_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19768354.2020.1721321","article-title":"How to interpret and integrate multi-omics data at systems level","volume":"24","author":"Jung","year":"2020","journal-title":"Anim Cells Syst (Seoul)"},{"key":"10.1016\/j.drudis.2026.104836_b0265","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.copbio.2003.10.006","article-title":"Interplay of transcriptomics and proteomics","volume":"14","author":"Hegde","year":"2003","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.drudis.2026.104836_b0270","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a000588","article-title":"Metabolomics: an emerging but powerful tool for precision medicine","volume":"1","author":"Clish","year":"2015","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"10.1016\/j.drudis.2026.104836_b0275","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1021\/acs.jproteome.3c00790","article-title":"Multiomics evaluation of human iPSCs and iPSC-derived neurons","volume":"23","author":"Lee","year":"2024","journal-title":"J Proteome Res"},{"key":"10.1016\/j.drudis.2026.104836_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113466","article-title":"NGLY1 mutations cause protein aggregation in human neurons","volume":"42","author":"Manole","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.drudis.2026.104836_bib426","doi-asserted-by":"crossref","unstructured":"Amniouel S, Shyr ZA, Borschel WF, Tambe M, Farkhondeh A, Zheng W. Genotype-specific molecular and functional trajectories in NGLY1 deficiency: a comparative multi-omics study of patient-derived iPSC neurons. Original Research. Frontiers in Cell and Developmental Biology. 2026;14. https:\/\/doi.org\/10.3389\/fcell.2026.1966226.","DOI":"10.3389\/fcell.2026.1966226"},{"key":"10.1016\/j.drudis.2026.104836_b0285","doi-asserted-by":"crossref","first-page":"12645","DOI":"10.3390\/ijms241612645","article-title":"Acid sphingomyelinase deficiency Type B patient-derived liver organoids reveals altered lysosomal gene expression and lipid homeostasis","volume":"24","author":"Gomez-Mariano","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104836_b0290","doi-asserted-by":"crossref","first-page":"29708","DOI":"10.1038\/s41598-025-12682-4","article-title":"Lysosomal free sialic acid storage disorder iPSC-derived neural cells display altered glycosphingolipid metabolism","volume":"15","author":"Sabir","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104836_b0295","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s11689-026-09699-9","article-title":"Multi-omics characterization of developing forebrain organoids unravels the dynamic molecular events of Rett syndrome pathogenesis","volume":"18","author":"Koetsier","year":"2026","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.drudis.2026.104836_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fbinf.2022.927312","article-title":"A review of feature selection methods for machine learning-based disease risk prediction","volume":"2","author":"Pudjihartono","year":"2022","journal-title":"Front Bioinform"},{"key":"10.1016\/j.drudis.2026.104836_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.asoc.2021.107956","article-title":"Recursive elimination\u2013election algorithms for wrapper feature selection","volume":"113","author":"Liu","year":"2021","journal-title":"Appl Soft Comput"},{"key":"10.1016\/j.drudis.2026.104836_b0360","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00167-022-07233-7","article-title":"Unsupervised machine learning methods and emerging applications in healthcare","volume":"31","author":"Eckhardt","year":"2023","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.drudis.2026.104836_b0330","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.beth.2020.05.002","article-title":"Supervised machine learning: a brief primer","volume":"51","author":"Jiang","year":"2020","journal-title":"Behav Ther"},{"key":"10.1016\/j.drudis.2026.104836_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.eswa.2023.122778","article-title":"A review of ensemble learning and data augmentation models for class imbalanced problems: combination, implementation and evaluation","volume":"244","author":"Khan","year":"2024","journal-title":"Expert Syst Appl"},{"key":"10.1016\/j.drudis.2026.104836_b0370","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40537-022-00652-w","article-title":"Transfer learning: a friendly introduction","volume":"9","author":"Hosna","year":"2022","journal-title":"J Big Data"},{"key":"10.1016\/j.drudis.2026.104836_b0310","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.3390\/app14209305","article-title":"Unsupervised learning in precision medicine: unlocking personalized healthcare through AI","volume":"14","author":"Trezza","year":"2024","journal-title":"Appl Sci"},{"key":"10.1016\/j.drudis.2026.104836_b0315","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/cancers18091427","article-title":"Clustering digestive tract tumors using transcriptomic and mutation data","volume":"18","author":"Tally","year":"2026","journal-title":"Cancers"},{"key":"10.1016\/j.drudis.2026.104836_b0320","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20178124","article-title":"Multi-omics factor analysis\u2014a framework for unsupervised integration of multi-omics data sets","volume":"14","author":"Argelaguet","year":"2018","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.drudis.2026.104836_b0325","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41592-020-01050-x","article-title":"Joint probabilistic modeling of single-cell multi-omic data with totalVI","volume":"18","author":"Gayoso","year":"2021","journal-title":"Nat Methods"},{"key":"10.1016\/j.drudis.2026.104836_b0335","doi-asserted-by":"crossref","DOI":"10.1093\/jamiaopen\/ooac053","article-title":"Clinical study applying machine learning to detect a rare disease: results and lessons learned","volume":"5","author":"Hersh","year":"2022","journal-title":"JAMIA Open"},{"key":"10.1016\/j.drudis.2026.104836_b0340","first-page":"521","article-title":"Improving machine learning with ensemble learning on observational healthcare data","volume":"2023","author":"Naderalvojoud","year":"2024","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.drudis.2026.104836_b0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pdig.0000014","article-title":"Transfer learning for non-image data in clinical research: a scoping review","volume":"1","author":"Ebbehoj","year":"2022","journal-title":"PLOS Digit Health"},{"key":"10.1016\/j.drudis.2026.104836_b0350","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s41586-024-08338-4","article-title":"The Human Cell Atlas from a cell census to a unified foundation model","volume":"637","author":"Rood","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104836_b0355","article-title":"MMOSurv: meta-learning for few-shot survival analysis with multi-omics data","volume":"41","author":"Wen","year":"2025","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2026.104836_b0375","doi-asserted-by":"crossref","first-page":"D730","DOI":"10.1093\/nar\/gkae1113","article-title":"The STRING database in 2025: protein networks with directionality of regulation","volume":"53","author":"Szklarczyk","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104836_b0380","doi-asserted-by":"crossref","first-page":"D1405","DOI":"10.1093\/nar\/gkac1033","article-title":"Pharos 2023: an integrated resource for the understudied human proteome","volume":"51","author":"Kelleher","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104836_b0385","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.914017","article-title":"Identification of therapeutic targets for amyotrophic lateral sclerosis using PandaOmics\u2014an AI-enabled biological target discovery platform","volume":"14","author":"Pun","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.drudis.2026.104836_b0390","doi-asserted-by":"crossref","first-page":"9980","DOI":"10.1038\/s41467-026-76837-1","article-title":"Drug screen and machine learning predict neuroprotective agents in a preclinical human model of childhood dementia","volume":"17","author":"Greenberg","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104836_b0395","article-title":"Large language models for drug discovery and development","volume":"6","author":"Zheng","year":"2025","journal-title":"Patterns (N Y)"},{"key":"10.1016\/j.drudis.2026.104836_b0400","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae338","article-title":"A survey of generative AI for de novo drug design: new frontiers in molecule and protein generation","volume":"25","author":"Tang","year":"2024","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.drudis.2026.104836_b0405","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12915-026-02575-x","article-title":"Generative AI in structure-based drug discovery","volume":"24","author":"Zhong","year":"2026","journal-title":"BMC Biol"},{"key":"10.1016\/j.drudis.2026.104836_b0410","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2024.0674","article-title":"Scientific hypothesis generation by large language models: laboratory validation in breast cancer treatment","volume":"22","author":"Abdel-Rehim","year":"2025","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.drudis.2026.104836_b0415","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41586-026-10549-w","article-title":"Evaluating large language models for accuracy incentivizes hallucinations","volume":"653","author":"Kalai","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104836_b0420","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41580-023-00615-w","article-title":"The technological landscape and applications of single-cell multi-omics","volume":"24","author":"Baysoy","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2026.104836_b0425","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s43441-025-00763-5","article-title":"Regulatory, translational, and operational considerations for the incorporation of biomarkers in drug development","volume":"59","author":"Hatcher","year":"2025","journal-title":"Ther Innov Regul Sci"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626002412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626002412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:40:34Z","timestamp":1793392834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626002412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1359644626002412"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104836","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104836"}}